Press release
AI in Cancer Diagnostics Market Size to Hit US$ 2.0 Bn, Globally, by 2031, Expanding at a CAGR of 11.2%
The global AI in cancer diagnostics market is projected to flourish at a CAGR of 11.2% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 2.0 billion is anticipated for the market in 2031. As of 2023, the market for AI in cancer diagnostics is expected to close at US$ 955 million.The increasing global incidence of cancer cases has created a pressing need for accurate and efficient diagnostic tools, and an increase in awareness about early diagnosis of cancer is likely to drive global AI in cancer diagnostics market demand in the next few years. Advancements in imaging technology and the integration of AI with advanced imaging technologies like MRI, CT scans, and mammography enhance the precision and sensitivity of cancer detection. AI-powered cancer diagnostics process ensures consistent and reliable results,
The availability of large volumes of medical data, including medical images, genetic information, and patient records, provides a foundation for training AI algorithms, AI, with its ability to analyze massive volumes of complex medical data and extract insights, is revolutionizing the landscape of cancer diagnosis. The integration of AI in cancer diagnostics helps in early detection, precise diagnosis, and tailored treatment strategies, ultimately leading to improved patient outcomes, and boosting the market demand.
For more insights into the Market, Request a Sample of this Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85783
Key Takeaways from the Market Study
As of 2022, the AI in the cancer diagnostics market was valued at US$ 859.0 million on application, the screening & diagnosis segment is projected to account for the largest global AI for cancer diagnostics market share
Based on end-users, the diagnostic center's segment held a significant market share in AI in the cancer diagnostics market.
Based on cancer type, the breast cancer segment dominated the global AI in cancer diagnostics as breast cancer is one of the most commonly diagnosed cancers globally, affecting a large number of individuals
AI in Cancer Diagnostics: Key Trends and Opportunistic Frontiers
Continuous advancements in AI technologies, such as deep learning and machine learning, enhance the capabilities and versatility of diagnostic algorithms.
Increasing application of AI-powered technologies, such as computer-aided detection (CAD) systems, can assist radiologists in analyzing mammograms and other breast imaging modalities, aiding in early detection and diagnosis.
AI in Cancer Diagnostics Market- Regional Analysis
North America accounted for a significant share of the global AI in the cancer diagnostics market. The growth of the market in the region is attributed to a strong foundation in research & development and encouragement for innovation in AI applications for cancer diagnostics in the region.
AI in cancer diagnostics in Asia Pacific is expected to witness significant market expansion during the forecast period. Increasing investment in healthcare infrastructure and adopting advanced technologies, including AI, for cancer diagnostics.
For In-depth Competitive Analysis, Buy Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=85783<ype=S
Competitive Landscape
The global AI in cancer diagnostics market is consolidated, with the presence of a few market players. Most companies are making significant investments in research & development activities. Transparency Market Research has profiled the following players in its global AI in cancer diagnostics market report:
Ibex Medical Analytics
EarlySign
Cancer Center.ai
Microsoft
Flatiron
Path AI
Therapixel
Tempus
Paige AI, Inc.
Kheiron Medical Technologies Limited
SkinVision
Freenome
Whiterabbit.ai
Mindpeak GmbH
Key Developments in the AI in Cancer Diagnostics Market
In March 2023 - Alverno Laboratories, and Ibex Medical Analytics, announced a new agreement to expand the deployment of Ibex's GalenTM suite of Artificial Intelligence (AI) solutions to the entire Alverno network across Illinois and Indiana. The deployment includes AI-powered solutions for cancer diagnosis across multiple tissue types and will support Alverno pathologists in providing the utmost quality of care for their patients.
In February 2022 - Freenome, announced the initiation of Vallania, a clinical study for the refinement and further development of its multiomics platform to detect multiple cancers. The platform uses a routine blood draw and combines both tumor and non-tumor signals with machine learning to detect cancers in the earliest, most treatable stages.
Request for Customization and Redefine Expectations: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id= 85783
AI in Cancer Diagnostics Market- Key Segments
Component
Software Solutions
Services
Cancer Type
Breast Cancer
Prostate Cancer
Lung Cancer
Colorectal Cancer
Cervical Cancer
Others
Application
Screening & Diagnosis
Tumor Identification
Monitoring
End-user
Hospitals
Diagnostic Centers
Medical Research Institutes
Contract Research Organizations
Region
North America
Europe
Asia Pacific
Middle East & Africa
South America
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Cancer Diagnostics Market Size to Hit US$ 2.0 Bn, Globally, by 2031, Expanding at a CAGR of 11.2% here
News-ID: 3361911 • Views: …
More Releases from transparencymarketresearch
On-body Drug Delivery Devices Market to Reach USD 796.1 Million by 2034, Growing …
The On-body Drug Delivery Devices Market is set for consistent growth, rising from USD 390.7 million in 2023 to USD 796.1 million by 2034. This reflects a solid CAGR of 6.8% from 2024 to 2034, driven by increasing demand for convenient, patient-friendly drug delivery solutions, especially for chronic conditions requiring regular dosing. The shift toward self-administration, advancements in wearable medical technology, and improved treatment adherence are further accelerating market expansion…
Global Oncology Nutrition Market to Reach USD 3.6 Billion by 2031, Growing at 6. …
The Global Oncology Nutrition Market is projected to grow steadily, rising from USD 2.1 billion in 2022 to USD 3.6 billion by 2031. With a CAGR of 6.2% from 2023 to 2031, this growth is driven by the increasing prevalence of cancer, rising awareness about the role of specialized nutrition in treatment outcomes, and the growing adoption of personalized dietary solutions for cancer patients. As healthcare providers emphasize nutrition as…
Oncolytic Virus Immunotherapy Market to Reach USD 572.2 Million by 2031, Growing …
The Oncolytic Virus Immunotherapy Market is poised for remarkable growth, increasing from USD 110.2 million in 2022 to USD 572.2 million by 2031. This surge, driven by a powerful CAGR of 21.1% from 2023 to 2031, reflects rising demand for advanced cancer treatments, expanding clinical trials, and increasing adoption of immunotherapy approaches that harness engineered viruses to selectively target and destroy cancer cells. As innovation accelerates in oncology, the market…
Global On-demand Transportation Market to Reach USD 287.6 Billion by 2031, Growi …
The On-demand Transportation Market is set for strong expansion, rising from USD 153.2 billion in 2022 to USD 287.6 billion by 2031. This reflects a robust CAGR of 7.2% from 2023 to 2031, driven by increasing adoption of ride-hailing, car-sharing, and micro-mobility services, along with growing smartphone penetration and improved digital payment ecosystems. As consumers shift toward flexible, convenient, and cost-effective mobility solutions, the on-demand transportation industry continues to accelerate…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
